Trial of the Treatment of Chronic Laryngitis With Amitryptiline

Laryngeal Diseases Clinical Trial

Official title:
Double-blind Placebo Controlled Trial of the Treatment of Chronic Laryngitis With Amitryptiline

Status Terminated

Clinical Trial Summary

The study will compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis. At the baseline visit, subjects will be assigned at random to amitriptyline or placebo which they will take for 8 weeks. Subjects will be seen in the clinic at baseline and at 8 weeks. Improvement will be measured using standardized symptom scales, and a self-reported subjective improvement percentage.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02434523
Study type	Interventional
Source	Boston Medical Center
Contact
Status	Terminated
Phase	Phase 2/Phase 3
Start date	September 2013
Completion date	January 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01276418` - ENT FiberLase CO2 Study	N/A
Recruiting	`NCT04575142` - Comparison of Office-based KTP and CO2 Laser Outcomes in Patients With Vocal Cord Lesions.	N/A
Completed	`NCT02960243` - Deep Brain Stimulation for Voice Tremor: Left, Right, or Both Hemispheres?	N/A
Terminated	`NCT02552225` - Treatment of Chronic Laryngitis With Amitriptyline	Phase 2/Phase 3